HONG KONG† July 6, 2022 /PRNewswire/ — Endurance RP Limited’s (“Endurance Longevity” or the “Company” and together with its subsidiaries, the “Group”; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inca Hong-Kong-based AI innovator and a leading provider of deep biomarkers of aging and longevity is pleased to announce several significant updates that contribute to its expanding journey.
Recruitment of new Chief Executive Officer
Deep Longevity has hired a new Chief Executive Officer, Deepankar (deep) Nayak, to bring experienced professional talent to redefine the company’s strategy and drive the organization forward. Deep has over 17 years of experience in technology consulting and has worked with major pharmaceutical clients in: the United States (“USA”), United Kingdom (“UK”), Europe† Japan and the Middle East†
Building and commercializing obsolete clocks
Deep Longevity is committed to building and commercializing various aging clocks using artificial intelligence (“AI”)-led deep learning models. The company is placing a special focus on its MindAge© offering as it seeks to capitalize on the strong demand in the virtual mental health market. The total addressable market is approximately $89 billion (or about HK$694.2 billion) only in the US.
Deep Longevity is considering establishing an enterprise-level MindAge© offering (web and app-based) targeting large and medium-sized employers in the US, UK and Europe, which will be the platform of choice for employees to enhance their virtual mental wellbeing – be in a safe, secure, private and personalized environment in the workplace. This will be the company’s main focus for 2022 and 2023.
Collaboration with Dr. Nancy Etcoff
Deep Longevity announced its partnership with Dr. Nancy Etcoff from Harvard Medical School On June 21, 2022 to create a virtual mental health offering through deep learning-based biomarkers of aging and longevity. In co-authorship with Dr. Etcoff Deep Longevity published an article in Aging-US describing a machine learning approach to human psychology: “Optimizing future well-being with artificial intelligence: Self-organizing maps (SOMs) for the identification of Islands of emotional stability.”
Development of FuturSelf
FuturSelf, a free self-help application, has been developed in collaboration with a leading European insurtech innovation center to demonstrate the system’s potential. Data obtained on FuturSelf will be used to further develop Deep Longevity’s digital minimum viable product (MVP) approach to mental health with the aim of delivering business-to-business (B2B) software as a service (SaaS) © to offer. model for insurance companies, large corporations and other employers to empower their employees to monitor and nurture their own mental health and well-being.
To address how mental health can be managed to help employees better cope with the demands of work and maximize their productivity, Deep Longevity is focused on providing highly scalable and commercial solutions that can be applied cost-effectively in all sectors. By leveraging Deep Longevity’s digital approach to managing mental health, a valuable feedback loop is created that can help employees grow by increasing their motivation and productivity or enabling them to seek important and timely emotional support when that is necessary. Per employee, the cost to employers to provide this vital human resources function can be minimal. Ongoing discussions with major insurance companies and other multinational companies suggest that the commercial opportunities for Deep Longevity (via FuturSelf and other applications) are immense and geographically scalable in all markets worldwide.
Jamie GibsonDirector of the company said: “As one of the forerunners in the long-life AI market, we are excited to achieve this remarkable milestone together with the world’s top scientists. We are confident in the future of deep AI integration technologies in human psychology and the development of a digital solution to improve people’s mental health and overall well-being.”
Alex ZhavoronkovChief Longevity Officer of Deep Longevity commented, “I have devoted much of my life to advancing the science of Longevity and am pleased to announce that DL has found a person who not only shares that passion, but also brings the experience of build and commercialize products that will help us bring our innovation to global markets. DL’s legacy clocks will support the research and development that the Longevity industry will experience and I am confident that Deep will bring our legacy clocks to various industries will bring as we discover new applications of this technology.”
About deep life
Deep Longevity is a wholly owned subsidiary of Endurance Longevity (SEHK:0575.HK), a publicly traded company. Deep Longevity develops explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological and psychological levels. It is also developing systems for the emerging field of long-term medicine, enabling doctors to make better decisions about interventions that can slow or reverse the aging process. Deep Longevity has developed the Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging, called “deep aging clocks”, to provide a universal multifactorial measure of human biological age.
Originally incubated by Insilico Medicine, Deep Longevity began its independent journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity and artificial intelligence: ETP Ventures; the Human Longevity and Performance Impact Venture Fund; BOLD Capital partners; Longevity Vision Fund; Long VC; Michael Antonov, the co-founder of Oculus; and other expert AI and biotechnology investors. Deep Longevity has established a research partnership with Human Longevity, Inc., one of the most prominent longevity organizations, to provide a range of obsolete clocks to a network of cutting edge physicians and researchers.
About Endurance Longevity (Stock Code: 0575.HK)
Endurance Longevity is a diversified investment group based in Hong-Kong currently holds several corporate and strategic investments focused on the healthcare, wellness and life sciences sectors. The Group has a strong investment track record and is approximately $298 million to shareholders in the 21 years of financial reporting since the IPO.
This press release is being distributed by LBS Communications Consulting Limited.
SOURCE Endurance RP Limited